SciSparc Advances Its Phase IIb Clinical Trial in Patients with Tourette Syndrome with its Proprietary Drug Candidate SCI-110
January 18, 2022
SciSparc Provides Updates Upon Conclusion of 2021
December 29, 2021
January 18, 2022
December 29, 2021